Aster DM Quality Care Ltd's Q2 FY27 numbers came in strong, with revenue of Rs. 2,829.20 Cr (+136.32% YoY) and PAT growth of +165.75% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | November 06, 2026 |
|---|---|
| Revenue (Q2) | Rs. 2,829.20 Cr (+136.32% YoY) |
| PAT (Q2) | Rs. 322.38 Cr (+165.75% YoY) |
| EBITDA margin | 23.45% (+258 bps YoY) |
| EPS (Q2) | Rs. 3.19 (+49.77% YoY) |
First full post-merger quarter delivered revenue of Rs.2,829.20 Cr, 8.94% above the Q1 proforma run-rate, with segment EBIT margin up 180 bps YoY to 19.32% and pre-exceptional EBITDA margin of 23.45% tracking ahead of the 22% marker toward the 24-25% FY2028-29 target. Cost ratios improved across the board and cash conversion was healthy (CFO/PAT 1.80x), while the NCI profit share of 18.72% exceeded the guided 10-15% band and net debt of Rs.3,182.87 Cr reflects the enlarged perimeter. No prior guidance number was explicitly exceeded in the filing, so results are best characterized as on-track execution rather than a guidance beat.
| Metric | FY24P | FY25P | FY26P |
|---|---|---|---|
| Merged occupancy % | 65 | 63 | 62 |
| Merged ARPOB (Rs. '000) | 39.1 | 43.5 | 49.5 |
| Merged beds | 9,752 | 10,250 | 10,623 |
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.